1 | 1300031-52-0 | GSK1324726A | GSK1324726A | C25H23ClN2O3
| 抑制剂;细胞生物学试剂;小分子抑制剂,天然产物 | |
2 | 1580889-33-3 | Tolvaptan Impurity 7 | Tolvaptan Impurity 7 | C25H23ClN2O3
| | |
3 | 150683-27-5 | 托伐普坦杂质11 | Tolvaptan Impurity 11 | C25H23ClN2O3
| | |
4 | 88605-33-8 | 9,10-Anthracenedione, 1,4-diamino-7-chloro-2-(4-pentylphenoxy)- | 9,10-Anthracenedione, 1,4-diamino-7-chloro-2-(4-pentylphenoxy)- | C25H23ClN2O3
| | |
5 | 113456-82-9 | {2-(4-benzyl-1-piperidinyl)-5-nitrophenyl}(4-chlorophenyl)methanone | {2-(4-benzyl-1-piperidinyl)-5-nitrophenyl}(4-chlorophenyl)methanone | C25H23ClN2O3
| | |
6 | 42018-52-0 | Ethanone, 2-(4-benzoylphenoxy)-1-[4-(4-chlorophenyl)-1-piperazinyl]- | Ethanone, 2-(4-benzoylphenoxy)-1-[4-(4-chlorophenyl)-1-piperazinyl]- | C25H23ClN2O3
| | |
7 | 664972-05-8 | N-[[2-(benzyloxy)phenyl](cyano)methyl]-3-chloro-N-(2-methoxyphenyl)propanamide | N-[[2-(benzyloxy)phenyl](cyano)methyl]-3-chloro-N-(2-methoxyphenyl)propanamide | C25H23ClN2O3
| | |
8 | | 4-(4-TERT-BUTYLBENZYLOXY)-2-(4-CHLOROPHENYL)-3-OXO-3,4-DIHYDROQUINOXALINE 1-OXIDE | 4-(4-TERT-BUTYLBENZYLOXY)-2-(4-CHLOROPHENYL)-3-OXO-3,4-DIHYDROQUINOXALINE 1-OXIDE | C25H23ClN2O3
| | |
9 | 442555-32-0 | 2-(4-chloro-2-methylphenoxy)-N-[4-(5-isopropyl-1,3-benzoxazol-2-yl)phenyl]acetamide | 2-(4-chloro-2-methylphenoxy)-N-[4-(5-isopropyl-1,3-benzoxazol-2-yl)phenyl]acetamide | C25H23ClN2O3
| | |
10 | 309927-08-0 | 2-amino-4-{2-[(2-chlorobenzyl)oxy]phenyl}-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile | 2-amino-4-{2-[(2-chlorobenzyl)oxy]phenyl}-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile | C25H23ClN2O3
| | |